The current SMMT market cap is 2.71B. The company's latest EPS is USD -0.8774 and P/E is -4.42.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 220k | 14.42M | 0 | 0 | 822k |
Operating Income | -22.4M | -7.02M | -537.74M | -15.77M | -19.94M |
Net Income | -21.39M | -19.23M | -542.38M | -14.72M | -21.27M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 23.62M | 20.17M | 22.78M | 15.12M | 1M |
Operating Income | -27.47M | -53.19M | -86.19M | -72.09M | -609.65M |
Net Income | -29.13M | -52.7M | -88.6M | -78.78M | -614.93M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 155.33M | 664.17M | 254.9M | 237.37M | 218.48M |
Total Liabilities | 22.08M | 537.51M | 121.42M | 117.77M | 119.1M |
Total Equity | 133.25M | 126.65M | 133.48M | 119.6M | 99.38M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 96.25M | 102.5M | 113.37M | 664.17M | 202.95M |
Total Liabilities | 17.39M | 23.05M | 30.09M | 537.51M | 125.26M |
Total Equity | 78.86M | 79.45M | 83.28M | 126.65M | 77.69M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -46.77M | -41.58M | -13.13M | -42.4M | -57.3M |
Investing | -634k | -624k | -645.06M | -644.86M | -648.34M |
Financing | 100.18M | 620.24M | 80.11M | 80.03M | 80.26M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -20.76M | -48.11M | -72.59M | -41.58M | -76.76M |
Investing | -341k | -421k | -306k | -624k | -587.77M |
Financing | 49.51M | 50.55M | 77.92M | 620.24M | 86.51M |
Market Cap | 2.71B |
Price to Earnings Ratio | -4.42 |
Price to Sales Ratio | 2.77k |
Price to Cash Ratio | 38.08 |
Price to Book Ratio | 35 |
Dividend Yield | - |
Shares Outstanding | 700.84M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.27 (6.89%) |
Company Name | Summit Therapeutics Inc |
Address |
850 new burton road suite 201 wilmington, delaware 19904 |
Website | https://www.smmttx.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.